| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/14/1997 | EP0772678A1 Modulation of drug radiation resistant genes |
| 05/14/1997 | EP0772631A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772625A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 05/14/1997 | EP0772622A1 5'-dithio-modified oligonucleotides |
| 05/14/1997 | EP0772621A2 Oligonucleotides with anti-mdr-1 gene activity |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772607A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same |
| 05/14/1997 | EP0772456A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772441A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0615453B1 Anti-cancer immunotherapeutic vector constructs |
| 05/14/1997 | EP0514449B1 Novel anti-tumoral agent derived from dextran |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/14/1997 | CN1149836A Tin-117m-containing radio therapeutic agents |
| 05/14/1997 | CN1149588A Cyclic bonding inhibitor |
| 05/13/1997 | US5629436 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress |
| 05/13/1997 | US5629430 Anticarcinogenic agents |
| 05/13/1997 | US5629337 Methods for treating asthma using optically pure (-)-zileuton |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629303 Controlled release systems and low dose androgens |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5628988 Sunscreen agents |
| 05/13/1997 | US5628979 Reagent for tumor imaging and therapy |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016452A1 Purine derivatives and processes for their preparation |
| 05/09/1997 | WO1997016443A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016423A1 24-homo-26,27-hexafluoro-cholecalciferols |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016205A1 Antitumor agent |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016196A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 05/09/1997 | CA2235584A1 24-homo-26,27-hexafluoro-cholecalciferols |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771789A1 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |
| 05/07/1997 | EP0771210A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ $g(g)1 CHAIN |
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771208A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 05/07/1997 | EP0771194A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0727941A4 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149296A Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/07/1997 | CA2189501A1 Nk-1 receptor antagonists for the treatment of cancer |
| 05/06/1997 | US5627215 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 05/06/1997 | US5627207 Cancer |
| 05/06/1997 | US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones |
| 05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
| 05/06/1997 | US5627158 Antisense oligonucleotides of human regulatory subunit RI-.sub.α of camp dependent protein kinases for the treatment of cancer |
| 05/06/1997 | US5626845 Method to ameliorate osteolysis and metastasis |
| 05/06/1997 | US5626838 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 05/06/1997 | US5626829 Anticarcinogenic agents with protractors and needle guides for imaging |
| 05/06/1997 | CA2129143C Reversal of multi-drug resistance by tetraarylethylenes |
| 05/06/1997 | CA2098791C (s)-2,3-dihydropolyprenol, (s)-2,3-dihydropolyprenyl monophosphate, processes of preparing the same and agents for inhibiting the growth or metastasis of cancers comprising the same |
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770622A2 Cyclic adhesion inhibitors |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770093A1 Proteins from mammalian liver and their use in oncology |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0770079A1 Heterobicyclic derivatives |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769966A1 Biotin compounds for targetting tumors and sites of infection |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/02/1997 | EP0769932A1 Implanted device containing tumor cells for the treatment of cancer |
| 05/02/1997 | EP0649410B1 Anilide derivatives |
| 05/01/1997 | WO1997015686A1 Diagnosis of susceptibility to cancer and treatment thereof |